Boston Scientific (BSX) Gross Margin (2009 - 2026)
Boston Scientific (BSX) posted quarterly Gross Margin of 70.71% for Q2 2026, up 305.0% year-over-year from 17.46% in Q2 2025, and up 1.8% on a QoQ basis from 69.46% in Q1 2026.
Boston Scientific (BSX) Gross Margin (2009 - 2026) Analysis & Trends
Boston Scientific has reported Gross Margin for 18 years, with the latest figure at 70.71% in Q2 2026.
- Gross Margin for Q2 2026 came in at 70.71%, up 305.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 69.93% (up 166.0% YoY), and the FY2025 annual result was 69.01%, up 41.0% from the prior year.
- Gross Margin improved to 70.71% in Q2 2026, from 69.46% in the prior quarter.
- Over five years, Gross Margin peaked at 70.71% in Q2 2026 and troughed at 67.65% in Q2 2025.
- A 5-year average of 69.11% and a median of 68.98% in 2022 frame the typical range for Gross Margin.
- The widest annual swing landed in 2025, when Gross Margin plunged 152 bps; it then jumped 305 bps in 2026.
- A 5-year view of Gross Margin shows it stood at 68.85% in 2022, then gained by 1 bps to 69.23% in 2023, then declined by 2 bps to 67.86% in 2024, then grew by 3 bps to 69.6% in 2025, then advanced by 2 bps to 70.71% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 70.71% in Q2 2026, 69.46% in Q1 2026, and 69.6% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 45.84% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 70.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.71% |
| Mar 31, 2026 | 69.46% |
| Dec 31, 2025 | 69.60% |
| Sep 30, 2025 | 69.93% |
| Jun 30, 2025 | 67.65% |
| Mar 31, 2025 | 68.84% |
| Dec 31, 2024 | 67.86% |
| Sep 30, 2024 | 68.83% |
| Jun 30, 2024 | 69.17% |
| Mar 31, 2024 | 68.67% |
| Dec 31, 2023 | 69.23% |
| Sep 30, 2023 | 68.78% |
| Jun 30, 2023 | 70.63% |
| Mar 31, 2023 | 69.31% |
| Dec 31, 2022 | 68.85% |
| Sep 30, 2022 | 69.12% |
| Jun 30, 2022 | 68.83% |
| Mar 31, 2022 | 68.44% |
| Dec 31, 2021 | 68.92% |
| Sep 30, 2021 | 69.30% |